Dorzolamide + Timolol Eye Drop

Dorzolamide + Timolol eye drop are a combination ophthalmic medication used to reduce elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension. This dual-action formulation combines a carbonic anhydrase inhibitor with a beta-blocker to provide effective pressure control when monotherapy is insufficient.

Dorzolamide works by decreasing the production of aqueous humor, while timolol further reduces eye fluid formation through beta-adrenergic blockade. Together, they offer enhanced and sustained reduction of intraocular pressure with convenient dosing. This eye drop is widely prescribed due to its targeted ocular action and consistent therapeutic outcomes when used as directed by an eye care professional.

Dorzolamide (2% w/v) + Timolol (0.5% w/v) eye drops are a trusted product in glaucoma management and are supplied through regulated pharmaceutical channels to ensure quality, safety, and therapeutic reliability. It is formulated according to recognized quality standards, supporting dependable clinical performance under medical supervision.

Product Features

• Combination therapy for effective eye pressure control
• Dual-action formula for enhanced intraocular pressure reduction
• Suitable for open-angle glaucoma and ocular hypertension
• Clinically proven ophthalmic formulation
• Designed for topical ocular administration

How It Helps

• Reduces the production of aqueous humor
• Helps maintain healthy intraocular pressure
• Supports optic nerve protection
• Aids in long-term vision preservation